Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels.
about
Immune and inflammatory mechanisms in pulmonary arterial hypertensionInterdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologistsDNA Damage and Pulmonary HypertensionA comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?Right ventricular adaptation and failure in pulmonary arterial hypertension.The emerging role of AMPK in the regulation of breathing and oxygen supplyEmerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertensionA critical role for the protein apoptosis repressor with caspase recruitment domain in hypoxia-induced pulmonary hypertensionThe nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targetedHIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanismWorld Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension.Emerging Metabolic Therapies in Pulmonary Arterial Hypertension.Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.Pulmonary 2-deoxy-2-[(18)F]-fluoro-d-glucose uptake is low in treated patients with idiopathic pulmonary arterial hypertensionGene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapiesControlling anoxic tolerance in adult Drosophila via the cGMP-PKG pathwayNew trial designs and potential therapies for pulmonary artery hypertension.Coenzyme Q supplementation in pulmonary arterial hypertension.Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertensionPuerarin induces mitochondria-dependent apoptosis in hypoxic human pulmonary arterial smooth muscle cells.Sex hormones and vascular protection in pulmonary arterial hypertension.High altitude pulmonary hypertension: role of K+ and Ca2+ channels.Up-regulation of hexokinase1 in the right ventricle of monocrotaline induced pulmonary hypertension.Dichloroacetate selectively improves cardiac function and metabolism in female and male rainbow trout.The dichloroacetate dilemma: environmental hazard versus therapeutic goldmine--both or neither?Κ-opioid receptor stimulation improves endothelial function in hypoxic pulmonary hypertension.Metabolomic heterogeneity of pulmonary arterial hypertensionThe role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.Mitochondrial dynamics in pulmonary arterial hypertension.Human immunodeficiency virus transgenic rats exhibit pulmonary hypertensionBMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertensionAlterations of cellular bioenergetics in pulmonary artery endothelial cellsRight ventricular failure due to chronic pressure load: What have we learned in animal models since the NIH working group statement?Immunocapture and microplate-based activity and quantity measurement of pyruvate dehydrogenase in human peripheral blood mononuclear cells.O2 sensing in the human ductus arteriosus: redox-sensitive K+ channels are regulated by mitochondria-derived hydrogen peroxide.Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells.Hypoxic pulmonary vasoconstriction: role of ion channels.
P2860
Q26851508-0EF39078-3744-4F21-8696-628A4C8C78A4Q26860314-49A38A04-C3B7-40E2-AEFB-927871243ACDQ27005594-16D686D0-5B5F-46D6-BC21-6C52D8E7860CQ27026643-4B4EA954-2083-40A0-B23B-4776DE66A601Q27318422-D3D21F37-1781-44DB-AC1E-6BE87D293E64Q28072485-2C91BDBE-13EA-45BF-9D47-7B4950F28D0AQ28083183-3CFC1E56-ABE5-4E58-A059-5F72D082D425Q28513703-E5885265-2AF8-42A3-83C3-7213BB58FB88Q28567772-2F7CCEDF-D231-42E7-983E-64710D6DB2FBQ28583933-D7E76DD7-8136-4FCE-83D6-635C22A9E66BQ30248878-65BA2BC4-0EB5-4759-93EC-5143096C40B3Q30585014-699BA03A-F993-4F04-B00E-8EB942695187Q33593640-66FFF368-58AF-4EC3-85ED-6B300DC3E072Q33608219-86F814CD-46D9-46D7-8ACB-185C3E128EA5Q33703652-31DEE76C-931C-42C7-95E7-112BCC892A51Q33806143-363E3D0F-61F9-4698-A08A-1F98F01EE231Q33831900-35AFD5AE-D84B-4A31-BDFA-92C29905AAEDQ33849207-93B7217A-4D18-433C-9608-FC9B61562EBFQ33942138-B83142D3-D877-444E-8E71-3535F0F07252Q33982467-DED4966F-18C2-4D1B-925D-C9B3804CCF79Q34085977-8AD103F6-1C3F-48BA-9A8C-37EEF27DA326Q34127884-32AE395C-1219-4B79-B094-DAD9CF267774Q34212213-EFB6BECA-A685-4B8A-93ED-C8809BF8860FQ34297770-261CA5BE-388C-47A0-96F2-E8ACFAD3D3A2Q34314214-4B5C22AE-3F9E-48A1-A00D-40E4CD2F56A4Q34346381-08B3B99D-8AFC-4E5E-BFD0-0C3F76CA5CBFQ34519424-B9C06CA8-F348-4EEB-98C9-CCF2304E851EQ34580854-4432E3E9-69EB-47B9-AA6A-9163E911E765Q34716873-9850A081-D425-47F6-9603-2C5F097A9AB6Q35095550-00CD1786-E3BC-46DE-93F1-648EBFB0E91FQ35115789-AA3A3407-EC25-41D4-B275-03BC6132D1ECQ35116543-AA73570F-26FE-4A6C-A0BC-C76EA3145C3BQ35217383-D1B00D1A-6069-43D4-8B56-2C3322E57F2EQ35376926-65D60830-2A3B-4B68-8187-706CB70E535CQ35611704-E72BB12F-F28D-4BC5-9158-3123B98C1CA8Q35725663-06E10AAF-0C0D-4926-B042-82202727E964Q35734683-4494C236-4CCC-4702-87F2-4C2636B99789Q35768162-2C922E61-BC5A-4162-BD07-85EECB232C98Q35779717-1166E895-34A3-4949-805D-58BD9A65F7C9Q35980388-7B336DE2-8087-4035-9986-A75F88E57854
P2860
Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Dichloroacetate, a metabolic m ...... tage-gated potassium channels.
@en
Dichloroacetate, a metabolic m ...... tage-gated potassium channels.
@nl
type
label
Dichloroacetate, a metabolic m ...... tage-gated potassium channels.
@en
Dichloroacetate, a metabolic m ...... tage-gated potassium channels.
@nl
prefLabel
Dichloroacetate, a metabolic m ...... tage-gated potassium channels.
@en
Dichloroacetate, a metabolic m ...... tage-gated potassium channels.
@nl
P2093
P356
P1433
P1476
Dichloroacetate, a metabolic m ...... tage-gated potassium channels.
@en
P2093
Evangelos D Michelakis
Gary D Lopaschuk
Jason R B Dyck
Lakshmi Puttagunta
M Sean McMurtry
Rohit Moudgil
Ross Waite
Stephen L Archer
Teresa A Hopkins
Xi-Chen Wu
P304
P356
10.1161/HC0202.101974
P407
P577
2002-01-01T00:00:00Z